ACIP voted to recommend the use of FluMist
On Oct. 26, 2007, the Immunization Practices Advisory Committee (ACIP) voted to recommend the use of FluMist, the…
CDC published updated recommendations for prevention of hepatitis A virus infection
On Oct. 19, 2007, the U.S. Centers for Disease Control and Prevention (CDC) published updated recommendations for prevention…
CDC published updated recommendation for meningococcal vaccination of at-risk children age 2-10 years in MMWR
On Oct. 17, 2007, the Food and Drug Administration (FDA) approved quadrivalent meningococcal conjugate vaccine (MCV4) (Menactra®, Sanofi…
FDA approved Afluria, a new inactivated influenza vaccine for use in people age 18 years and older
On Sept. 28, 2007, the U.S. Food and Drug Administration (FDA) approved an Australian-made influenza vaccine called Afluria…
The CDC revised recommendations to vaccinate all persons ages 11-18 with MCV4 at earliest opportunity
On Aug 10, 2007, the U.S. Centers for Disease Control and Prevention (CDC) notified MMWR readers of revised…
Nonpharmaceutical interventions implemented by U.S. cities during the 1918-1919 influenza pandemic
On Aug. 8, 2007, JAMA reported that research demonstrated a strong association between early, sustained, and layered application…
HHS announced $175 million to assist states in pandemic influenza preparedness efforts
On Jul. 17, 2007, The US Department of Health and Human Services (HHS) announced it was providing states,…
HHS awarded $132.5 million to Sanofi Pasteur and MedImmune over five years to retrofit existing domestic vaccine manufacturing facilities
On Jun. 14, 2007, the U.D. of Health and Human Services (HHS) awarded $132.5 million to Sanofi Pasteur…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Oncology | Vaccine
National Cancer Institute reported risk of lymphoma increases with Hepatitis C virus infection
On May 8, 2007, the National Cancer Institute (NCI) reported that people infected with the hepatitis C virus…
Biotechnology | Chemical | Diagnostics | Infectious Disease | Life Science News | Medicine | Therapeutics | Vaccine
Livermore Lab developed pathogen signatures for bioterrorist attack Identification
In 2007, researchers at Livermore National Laboratory announced they had developed candidate signatures for pathogens that might be…
Lethal infection of K18-hACE2 mice infected with Severe Acute Respiratory Syndrome Coronavirus published
In January 2007, scientists at the University of Iowa reported in the Journal of Virology that they had…
The CDC responded to a multi-state outbreak of E coli infections
On Dec. 14, 2006, the U.S. Centers for Disease Control and Prevention (CDC) reported a multi-state outbreak of…
Rotavirus vaccine, live, oral, pentavalent was licensed for use in infants ages 6 to 32 weeks
On Feb. 3, 2006, Rotavirus vaccine, live, oral, pentavalent (RotaTeq by Merck) was licensed for use in infants…
The CDC’s advisory Committee recommended routine immunizations for children and adolescents of rotavirus and HPV
On Jan. 6, 2006, the U.S. Centers for Disease Control and Prevention’s (CDC) advisory Committee on Immunization Practices…
The CDC activated its Emergency Operations Center for Tropical Storm Ernesto
Aug. 24, 2024, the U.S. Centers for Disease Control and Prevention (CDC) activated its Emergency Operations Center (EOC)…
Agriculture | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine | Veterinary
The Kansas State University Biosecurity Research Institute was dedicated
In 2006, the Kansas State University Biosecurity Research Institute dedicated the Biosecurity Research Institute (BRI) that was designed…
Malaria Atlas Project was founded
In 2006, the Malaria Atlas Project (MAP) was founded as an international research collaboration that tracks the global…
CDC’s ACIP updated immunization strategy to eliminate transmission of Hepatitis B Virus infection in the U.S.
On Dec. 23, 2005, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
A final order on the anthrax vaccine was issued by FDA
On Dec. 19, 2005, in a 2-year legal battle over the U.S. military’s anthrax vaccination program, the Food…
Biotechnology | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
The Bill & Melinda Gates Foundation announced grants totaling $258 million to develop a malaria vaccine
On Oct. 30, 2005, the Bill & Melinda Gates Foundation announced three grants totaling $258.3 million for advanced…
A vaccine that combined the measles, mumps, rubella, and varicella antigens was licensed
On Sept. 6, 2005, the vaccine that combined the measles, mumps, rubella, and varicella antigens (Proquad by Merck)…
FDA approved lowering the age limit to 12 mos for one of the two licensed hepatitis A vaccine
On Aug. 11, 2005, the Food and Drug Administration (FDA) approved an application of a pediatric/adolescent formulation of…
FDA licensed a 2nd Tdap vaccine (Adacel by Sanofi Pasteur) for use in persons ages 11-64 years
On Jun. 9, 2005, the U.S. Food and Drug Administration (FDA) licensed a 2nd Tdap vaccine (Adacel by…
Sanofi Pasteur announced FDA approval of Menactra meningococcal conjugate vaccine indication for infants
On Apr. 22, 2005, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had granted licensure to…
CDC announced that rubella was no longer endemic in the U.S.
On Mar. 21, 2005, the U.S. Centers for Disease Control and Prevention (CDC) announced that a major public…
The CDC assisted with the public health response to the devastating tsunami in the Indian Ocean
On Dec. 26, 2004, the U.S. Centers for Disease Control and Prevention (CDC) assisted with an earthquake measuring…
Biotechnology | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
OHSU was awarded $4 million NIH biodefense contract to study tuberculosis
On Nov. 1, 2004, an Oregon Health & Science University (OHSU) research team announced that it was one…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics
OHSU announced collaboration with PNNL on biodefense project studying salmonella, pox viruses
On Sept. 14, 2004, researchers at OHSU and OHSU’s Vaccine and Gene Therapy Institute announced a collaboration with…
Biotechnology | Chemical | Diagnostics | FDA | Infectious Disease | Life Science News | Radiology | Therapeutics | U.S. Congress
Project BioShield Act authorized FDA to expedite review procedures for treatments for chemical, biological and nuclear agents
On Jul. 21, 2004, Project BioShield Act of 2004 was signed by President George W. Bush. The Act…
OHSU VGTI received a $3.5 million NIH grant to assist in development of AIDS vaccine
On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…